Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group (Q33584368)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group |
scientific article |
Statements
1 reference
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group (English)
1 reference
Virginia Savin
1 reference
Daniel Cattran
1 reference
Debbie S Gipson
1 reference
Melanie S Joy
1 reference
Leslie Powell
1 reference
Jacqueline MacHardy
1 reference
J Charles Jennette
1 reference
Suzanne Vento
1 reference
Cynthia Pan
1 reference
Allison Eddy
1 reference
Agnes B Fogo
1 reference
22 November 2009
1 reference
1 reference
55
1 reference
50-60
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference